Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;134(5):e346-e347.
doi: 10.1016/j.amjmed.2021.01.013.

The Reply

Peter A McCullough  1
Affiliations
Comment

The Reply

Peter A McCullough. Am J Med. 2021 May.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
The 4 pillars of pandemic response to the severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic crisis, reproduced with permission from McCullough et al.
See this image and copyright information in PMC

Comment on

References

    1. McCullough PA, Alexander PE, Armstrong R, et al. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) Rev Cardiovasc Med. 2020;21(4):517–530. doi: 10.31083/j.rcm.2020.04.264. - DOI - PubMed
    1. Palazzuoli A, Ruberto F, De Ferrari GM, et al. Inpatient mortality according to level of respiratory support received for severe acute respiratory syndrome coronavirus 2 (Coronavirus Disease 2019) infection: a prospective multicenter study. Crit Care Explor. 2020;2(9):e0220. doi: 10.1097/CCE.0000000000000220. - DOI - PMC - PubMed
    1. McCullough PA, Kelly RJ, Ruocco G, et al. Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) infection. Am J Med. 2021;134(1):16–22. doi: 10.1016/j.amjmed.2020.07.003. - DOI - PMC - PubMed
    1. Meizlish ML, Goshua G, Liu Y, Fine R, et al. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis [e-pub ahead of print]. medRxiv. Accessed December 30, 2020. doi: https://doi.org/10.1101/2021.01.12.21249577. - PMC - PubMed
    1. Billett HH, Reyes-Gil M, Szymanski J, et al. Anticoagulation in COVID-19: effect of enoxaparin, heparin, and apixaban on mortality. Thromb Haemost. 2020;120(12):1691–1699. doi: 10.1055/s-0040-1720978. - DOI - PMC - PubMed